FULC
Fulcrum Therapeutics, Inc.
Company overview
- Market capitalization
- $283.83M
- Employees
- 55
- Latest publication
- 2026-09-29
About Fulcrum Therapeutics, Inc.
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its clinical-stage product candidate is pociredir, a fetal hemoglobin inducer, which is in phase 1b clinical trial for the treatment of sickle cell disease and beta-thalassemia. The company also discovers programs for the treatment of diamond-blackfan anemia, Bone Marrow Failure Syndromes, novel fetal hemoglobin inducers, fibrotic disorders. It has licensce agreement with CAMP4 which includes certain small molecule compounds, composition of matter and method of use patent rights, and know-how to research, develop, manufacture, use, and commercialize. Fulcrum Therapeutics, Inc. was Incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 80,000,000USD |
| Cost Of Revenue | 338,000USD | -300,000USD | 14,296,000USD | 300,000USD | 13,404,000USD | 369,000USD | 14,639,000USD | 17,261,000USD |
| Gross Profit | -338,000USD | 300,000USD | -14,296,000USD | -300,000USD | -13,404,000USD | -369,000USD | -14,639,000USD | 62,739,000USD |
| Research Development | 14,084,000USD | 15,416,000USD | 14,296,000USD | 12,987,000USD | 13,404,000USD | 11,344,000USD | 14,639,000USD | 17,261,000USD |
| Selling General Administrative | 8,102,000USD | 7,277,000USD | 7,302,000USD | 6,828,000USD | 6,691,000USD | 7,716,000USD | 8,138,999USD | 9,976,000USD |
| Total Operating Expenses | 21,848,000USD | 22,993,000USD | 7,562,000USD | 19,515,000USD | 6,999,000USD | 19,060,000USD | 10,487,000USD | 10,247,000USD |
| Operating Income | -22,186,000USD | -22,693,000USD | -21,858,000USD | -19,815,000USD | -20,403,000USD | -19,429,000USD | -25,126,000USD | 52,492,000USD |
| Income Before Tax | -18,891,000USD | -20,334,000USD | -19,595,000USD | -17,296,000USD | -17,655,000USD | -16,568,000USD | -21,696,000USD | 55,409,000USD |
| Net Income | -18,891,000USD | -20,334,000USD | -19,595,000USD | -17,296,000USD | -17,655,000USD | -16,568,000USD | -21,696,000USD | 55,409,000USD |
| Net Income From Continuing Ops | -18,891,000USD | -20,334,000USD | -19,595,000USD | -17,296,000USD | -17,655,000USD | -16,568,000USD | -21,696,000USD | 55,409,000USD |
| Ebit | -18,891,000USD | -20,334,000USD | -19,595,000USD | -17,296,000USD | -17,655,000USD | -16,568,000USD | -23,063,000USD | 55,409,000USD |
| Ebitda | -18,553,000USD | -19,987,000USD | -19,249,000USD | -16,952,000USD | -17,302,000USD | -16,199,000USD | -22,694,000USD | 55,785,000USD |
| Depreciation And Amortization | 338,000USD | 347,000USD | 346,000USD | 344,000USD | 353,000USD | 369,000USD | 369,000USD | 376,000USD |
| Reconciled Depreciation | 338,000USD | 347,000USD | 346,000USD | 344,000USD | 353,000USD | 369,000USD | 369,000USD | 376,000USD |
| Total Other Income Expense Net | 3,295,000USD | 2,359,000USD | 2,263,000USD | 2,519,000USD | 2,748,000USD | 2,860,999USD | 3,430,000USD | 2,917,000USD |
| Unclassified Operating Expenses | — | — | -14,036,000USD | — | -13,096,000USD | — | -12,290,999USD | -16,990,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 19,163,000USD | 8,823,000USD | 750,000USD | 0USD | 0USD |
| Cost Of Revenue | 1,390,000USD | 2,515,000USD | 2,379,000USD | 2,053,000USD | 1,345,000USD | 715,000USD |
| Gross Profit | -1,390,000USD | 19,163,000USD | 8,823,000USD | -2,053,000USD | -1,345,000USD | -715,000USD |
| Research Development | 56,103,000USD | 69,701,000USD | 59,042,000USD | 71,072,000USD | 25,184,000USD | 18,494,000USD |
| Selling General Administrative | 28,666,000USD | 30,516,000USD | 21,392,000USD | 13,145,000USD | 8,314,000USD | 4,499,000USD |
| Unclassified Operating Expenses | -1,390,000USD | — | — | — | — | — |
| Total Operating Expenses | 83,379,000USD | 100,217,000USD | 80,434,000USD | 84,217,000USD | 33,498,000USD | 22,993,000USD |
| Operating Income | -84,769,000USD | -81,054,000USD | -71,611,000USD | -84,217,000USD | -33,498,000USD | -22,993,000USD |
| Income Before Tax | -74,880,000USD | -80,847,000USD | -70,819,000USD | -82,677,000USD | -32,588,000USD | -22,964,000USD |
| Net Income | -74,880,000USD | -78,332,000USD | -68,440,000USD | -79,113,000USD | -32,588,000USD | -22,964,000USD |
| Net Income From Continuing Ops | -74,880,000USD | -80,847,000USD | -70,819,000USD | -82,677,000USD | -32,588,000USD | -22,964,000USD |
| Ebit | -74,880,000USD | -81,054,000USD | -71,611,000USD | -84,217,000USD | -33,498,000USD | -22,993,000USD |
| Ebitda | -73,490,000USD | -78,539,000USD | -69,232,000USD | -82,164,000USD | -32,153,000USD | -22,278,000USD |
| Depreciation And Amortization | 1,390,000USD | 2,515,000USD | 2,379,000USD | 2,053,000USD | 1,345,000USD | 715,000USD |
| Reconciled Depreciation | 1,390,000USD | 2,515,000USD | 2,379,000USD | 2,053,000USD | 1,345,000USD | 715,000USD |
| Total Other Income Expense Net | 9,889,000USD | 207,000USD | 792,000USD | 1,540,000USD | 910,000USD | 29,000USD |
| Interest Expense | — | 2,722,000USD | 0USD | 0USD | 0USD | 0USD |
| Income Tax Expense | — | -2,515,000USD | -2,379,000USD | -3,564,000USD | 910,000USD | -1,000USD |
| Net Income Applicable To Common Shares | — | -80,847,000USD | -70,819,000USD | -89,805,000USD | -39,147,000USD | -25,371,000USD |
| Interest Income | — | — | — | 1,511,000USD | 518,000USD | 1,000USD |
| Net Interest Income | — | — | — | 1,511,000USD | 518,000USD | 1,000USD |
| Non Operating Income Net Other | — | — | — | — | 0USD | 0USD |
| Minority Interest | — | — | — | — | 0USD | 0USD |
| Discontinued Operations | — | — | — | — | 0USD | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 323,952,000USD | 346,770,000USD | 366,284,000USD | 214,858,000USD | 228,838,000USD | 242,649,000USD | 260,718,000USD | 279,008,000USD |
| Cash And Equivalents | 48,466,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 322,851,000USD | 338,669,000USD | 357,480,000USD | 205,863,000USD | 219,373,000USD | 232,556,000USD | 249,923,000USD | 267,489,000USD |
| Other Current Assets | 4,011,000USD | 3,577,000USD | 5,174,000USD | 5,218,000USD | 3,928,000USD | 3,412,000USD | 5,560,000USD | 6,599,000USD |
| Other Non Current Assets | 9,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 13,255,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 10,298,000USD | 9,864,000USD | 13,048,000USD | 11,632,000USD | 8,985,000USD | 8,100,000USD | 11,044,000USD | 14,509,000USD |
| Other Non Current Liabilities | 197,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 310,697,000USD | 333,303,000USD | 349,000,000USD | 198,366,000USD | 214,378,000USD | 228,486,000USD | 243,034,000USD | 257,291,000USD |
| Total Equity Including Noncontrolling Interest | 310,697,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 0USD | 6,354,000USD | 7,065,000USD | 7,785,000USD | 8,248,000USD | 8,882,000USD | 9,584,000USD | 10,242,000USD |
| Accounts Payable | 3,425,000USD | 2,450,000USD | 1,592,000USD | 2,856,000USD | 1,751,000USD | 1,507,000USD | 1,164,000USD | 4,041,000USD |
| Short Term Debt | 2,518,000USD | 2,461,000USD | 2,404,000USD | 2,348,000USD | 2,293,000USD | 2,239,000USD | 2,186,000USD | 2,134,000USD |
| Common Stock | 76,000USD | 67,000USD | 67,000USD | 54,000USD | 54,000USD | 54,000USD | 54,000USD | 54,000USD |
| Retained Earnings | -639,348,000USD | -613,169,000USD | -594,278,000USD | -573,944,000USD | -554,349,000USD | -537,053,000USD | -519,398,000USD | -502,830,000USD |
| Accumulated Other Comprehensive Income | -567,000USD | -513,000USD | 174,000USD | 241,000USD | 82,000USD | 70,000USD | 130,000USD | 379,000USD |
| Total Liab | — | 13,467,000USD | 17,284,000USD | 16,492,000USD | 14,460,000USD | 14,163,000USD | 17,684,000USD | 21,717,000USD |
| Other Current Liab | — | 4,953,000USD | 9,052,000USD | 6,428,000USD | 4,941,000USD | 4,354,000USD | 7,694,000USD | 8,334,000USD |
| Capital Stock | — | 67,000USD | 67,000USD | 54,000USD | 54,000USD | 54,000USD | 54,000USD | 54,000USD |
| Cash | — | 50,261,000USD | 197,533,000USD | 47,078,000USD | 42,588,000USD | 42,178,000USD | 58,212,000USD | 72,630,000USD |
| Cash And Short Term Investments | — | 333,316,000USD | 352,306,000USD | 200,645,000USD | 214,111,000USD | 226,603,000USD | 241,021,000USD | 257,234,000USD |
| Net Debt | — | -44,394,000USD | -191,090,000USD | -40,067,000USD | -35,017,000USD | -34,073,000USD | -49,583,000USD | -63,485,000USD |
| Short Long Term Debt Total | — | 5,867,000USD | 6,443,000USD | 7,011,000USD | 7,571,000USD | 8,105,000USD | 8,629,000USD | 9,145,000USD |
| Short Term Investments | — | 283,055,000USD | 154,773,000USD | 153,567,000USD | 171,523,000USD | 184,425,000USD | 182,809,000USD | 184,604,000USD |
| Net Receivables | — | 1,776,000USD | 1,070,000USD | 934,000USD | 1,334,000USD | 2,541,000USD | 3,342,000USD | 3,656,000USD |
| Property Plant Equipment Gross | — | 21,579,000USD | 22,712,000USD | 23,085,000USD | 23,201,000USD | 23,492,000USD | 23,841,000USD | 24,130,000USD |
| Common Stock Shares Outstanding | — | 76,215,000shares | 63,355,000shares | 62,597,000shares | 62,544,000shares | 62,479,000shares | 53,954,000shares | 62,409,000shares |
| Non Current Assets Total | — | 8,101,000USD | 8,804,000USD | 8,995,000USD | 9,465,000USD | 10,093,000USD | 10,795,000USD | 11,519,000USD |
| Non Current Liabilities Total | — | 3,603,000USD | 4,236,000USD | 4,860,000USD | 5,475,000USD | 6,063,000USD | 6,640,000USD | 7,208,000USD |
| Non Current Liabilities Other | — | 197,000USD | 197,000USD | 197,000USD | 197,000USD | 197,000USD | 197,000USD | 197,000USD |
| Non Currrent Assets Other | — | 1,747,000USD | 1,739,000USD | 1,210,000USD | 1,217,000USD | 1,211,000USD | 1,211,000USD | 1,277,000USD |
| Net Working Capital | — | 328,805,000USD | 344,432,000USD | 194,231,000USD | 210,388,000USD | 224,456,000USD | 238,879,000USD | 252,980,000USD |
| Unclassified Non Current Liabilities | — | 3,406,000USD | 4,039,000USD | 4,663,000USD | 5,278,000USD | 5,866,000USD | 6,443,000USD | 7,011,000USD |
| Unclassified Equity | — | 946,851,000USD | 942,970,000USD | 771,961,000USD | 768,537,000USD | 765,361,000USD | 762,194,000USD | 759,634,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 366,284,000USD | 260,718,000USD | 257,694,000USD | 226,685,000USD | 235,000,000USD | 129,577,000USD | 110,439,000USD | 85,771,000USD |
| Other Current Assets | 5,174,000USD | 5,560,000USD | 3,729,000USD | 3,517,000USD | 4,199,000USD | 74,000USD | 284,000USD | 797,000USD |
| Total Liab | 17,284,000USD | 17,684,000USD | 22,501,000USD | 27,743,000USD | 23,461,000USD | 34,396,000USD | 23,286,000USD | 9,771,000USD |
| Total Stockholder Equity | 349,000,000USD | 243,034,000USD | 235,193,000USD | 198,942,000USD | 211,539,000USD | 95,181,000USD | 87,153,000USD | 76,000,000USD |
| Other Current Liab | 9,052,000USD | 7,694,000USD | 8,726,000USD | 9,551,000USD | 74,000USD | 7,719,000USD | 5,915,000USD | 2,920,000USD |
| Common Stock | 67,000USD | 54,000USD | 62,000USD | 52,000USD | 41,000USD | 28,000USD | 23,000USD | 16,000USD |
| Capital Stock | 67,000USD | 54,000USD | 62,000USD | 52,000USD | 41,000USD | 28,000USD | 23,000USD | 16,000USD |
| Retained Earnings | -594,278,000USD | -519,398,000USD | -509,673,000USD | -412,338,000USD | -302,467,000USD | -221,620,000USD | -150,801,000USD | -68,124,000USD |
| Cash | 197,533,000USD | 58,212,000USD | 25,563,000USD | 35,098,000USD | 35,412,000USD | 57,052,000USD | 96,713,000USD | 72,797,000USD |
| Cash And Short Term Investments | 352,306,000USD | 241,021,000USD | 236,221,000USD | 202,921,000USD | 218,162,000USD | 112,914,000USD | 96,713,000USD | 72,797,000USD |
| Total Current Assets | 357,480,000USD | 249,923,000USD | 242,199,000USD | 207,519,000USD | 225,998,000USD | 112,914,000USD | 100,083,000USD | 74,095,000USD |
| Total Current Liabilities | 13,048,000USD | 11,044,000USD | 13,675,000USD | 16,725,000USD | 19,199,000USD | 26,725,000USD | 12,140,000USD | 4,229,000USD |
| Net Debt | -191,090,000USD | -49,583,000USD | -14,742,000USD | -21,675,000USD | -35,412,000USD | -57,035,000USD | -96,663,000USD | -72,751,000USD |
| Short Term Debt | 2,404,000USD | 2,186,000USD | 2,192,000USD | 2,602,000USD | 9,626,000USD | 17,000USD | 50,000USD | 46,000USD |
| Short Long Term Debt Total | 6,443,000USD | 8,629,000USD | 10,821,000USD | 13,423,000USD | 469,000USD | 17,000USD | 50,000USD | 46,000USD |
| Short Term Investments | 154,773,000USD | 182,809,000USD | 210,658,000USD | 167,823,000USD | 182,750,000USD | 55,862,000USD | — | 0USD |
| Net Receivables | 1,070,000USD | 3,342,000USD | 2,249,000USD | 1,081,000USD | 4,110,000USD | 2,707,000USD | 111,000USD | 501,000USD |
| Accounts Payable | 1,592,000USD | 1,164,000USD | 2,757,000USD | 3,638,000USD | 4,788,000USD | 4,079,000USD | 2,186,000USD | 1,263,000USD |
| Property Plant Equipment Net | 7,065,000USD | 9,584,000USD | 12,392,000USD | 15,969,000USD | 7,368,000USD | 8,397,000USD | 87,943,000USD | 10,546,000USD |
| Property Plant Equipment Gross | 22,712,000USD | 23,841,000USD | 25,152,000USD | 6,906,000USD | 7,368,000USD | 8,397,000USD | 9,205,000USD | 10,546,000USD |
| Accumulated Other Comprehensive Income | 174,000USD | 130,000USD | -136,000USD | -797,000USD | -397,000USD | -2,000USD | -110,439,000USD | -1,958,000USD |
| Common Stock Shares Outstanding | 63,355,000shares | 61,984,000shares | 61,310,000shares | 44,991,000shares | 35,361,000shares | 25,354,000shares | 22,664,500shares | 16,940,000shares |
| Non Current Assets Total | 8,804,000USD | 10,795,000USD | 15,495,000USD | 19,165,999USD | 9,002,000USD | 16,663,000USD | 10,356,000USD | 11,676,000USD |
| Non Current Liabilities Total | 4,236,000USD | 6,640,000USD | 8,826,000USD | 11,017,999USD | 4,262,000USD | 7,671,000USD | 11,146,000USD | 5,542,000USD |
| Non Current Liabilities Other | 197,000USD | 197,000USD | 197,000USD | 197,000USD | — | 3,051,000USD | 55,000USD | 150,000USD |
| Non Currrent Assets Other | 1,739,000USD | 1,211,000USD | 3,103,000USD | 2,104,999USD | 542,000USD | 7,174,000USD | -78,679,000USD | 38,000USD |
| Net Working Capital | 344,432,000USD | 238,879,000USD | 228,524,000USD | 190,794,000USD | 206,799,000USD | 92,785,000USD | 87,943,000USD | 69,866,000USD |
| Unclassified Non Current Liabilities | 4,039,000USD | 6,443,000USD | 8,629,000USD | 6,003,999USD | — | -7,671,000USD | — | — |
| Unclassified Equity | 942,970,000USD | 762,194,000USD | 744,878,000USD | 611,973,000USD | 514,321,000USD | 316,747,000USD | 348,347,000USD | 146,050,000USD |
| Current Deferred Revenue | — | — | 1,426,000USD | 934,000USD | 4,711,000USD | 14,910,000USD | 3,989,000USD | 2,800,000USD |
| Unclassified Current Liabilities | — | — | -1,426,000USD | — | — | — | — | -2,800,000USD |
| Deferred Long Term Liab | — | — | — | 4,620,000USD | — | 4,620,000USD | — | 0USD |
| Other Liab | — | — | — | 197,000USD | 4,262,000USD | 7,671,000USD | 11,146,000USD | 5,542,000USD |
| Other Assets | — | — | — | 3,197,000USD | 1,634,000USD | 1,670,000USD | 1,151,000USD | 1,130,000USD |
| Inventory | — | — | — | -473,000USD | -473,000USD | -2,781,000USD | 2,975,000USD | 559,000USD |
| Net Tangible Assets | — | — | — | 198,942,000USD | 211,539,000USD | 95,181,000USD | 87,153,000USD | -63,670,000USD |
| Unclassified Non Current Assets | — | — | — | -2,105,000USD | — | — | -78,738,000USD | — |
| Unclassified Current Assets | — | — | — | — | — | -2,781,000USD | — | — |
| Intangible Assets | — | — | — | — | — | — | — | 0USD |
| Good Will | — | — | — | — | — | — | — | 0USD |
| Short Long Term Debt | — | — | — | — | — | — | — | 0USD |
| Long Term Debt | — | — | — | — | — | — | — | 0USD |
| Long Term Investments | — | — | — | — | — | — | — | 0USD |
| Accumulated Depreciation | — | — | — | — | — | — | — | 0USD |
| Additional Paid In Capital | — | — | — | — | — | — | — | 0USD |
| Treasury Stock | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -18,891,000USD | -20,334,000USD | -19,595,000USD | -17,296,000USD | -17,655,000USD | -16,568,000USD | -21,696,000USD | 55,409,000USD |
| Depreciation | 338,000USD | 347,000USD | 346,000USD | 344,000USD | 353,000USD | 369,000USD | 400,000USD | 400,000USD |
| Stock Based Compensation | 3,860,000USD | 3,066,000USD | 3,360,000USD | 2,875,000USD | 3,167,000USD | 2,477,000USD | 3,817,000USD | 4,344,000USD |
| Other Non Cash Items | -767,000USD | -383,000USD | -586,000USD | -1,085,000USD | -899,000USD | -945,000USD | 2,634,000USD | 3,186,000USD |
| Change In Working Capital | -3,290,000USD | 506,000USD | 2,285,000USD | 1,342,000USD | -223,000USD | -2,094,000USD | -410,000USD | -96,000USD |
| Total Cash From Operating Activities | -18,750,000USD | -16,798,000USD | -14,190,000USD | -13,820,000USD | -15,257,000USD | -16,761,000USD | -19,072,000USD | 58,899,000USD |
| Capital Expenditures | -8,000USD | -159,000USD | -90,000USD | -65,000USD | 0USD | -231,000USD | -19,000USD | 0USD |
| Free Cash Flow | -18,758,000USD | -16,957,000USD | -14,280,000USD | -13,885,000USD | -15,257,000USD | -16,992,000USD | -19,091,000USD | 58,899,000USD |
| Investments | -128,202,000USD | -890,000USD | 18,612,000USD | 13,933,000USD | -777,000USD | 2,260,000USD | 4,350,000USD | -12,508,000USD |
| Total Cashflows From Investing Activities | -128,210,000USD | -1,049,000USD | 18,612,000USD | 13,933,000USD | -777,000USD | 2,260,000USD | 4,350,000USD | -12,508,000USD |
| Total Cash From Financing Activities | -312,000USD | 168,302,000USD | 64,000USD | 301,000USD | 0USD | 83,000USD | 635,000USD | 377,000USD |
| Change In Cash | -147,272,000USD | 150,455,000USD | 4,486,000USD | 414,000USD | -16,034,000USD | -14,418,000USD | -14,072,000USD | 46,753,000USD |
| Begin Period Cash Flow | 198,734,000USD | 48,279,000USD | 43,793,000USD | 43,379,000USD | 59,413,000USD | 73,831,000USD | 86,702,000USD | 39,949,000USD |
| End Period Cash Flow | 51,462,000USD | 198,734,000USD | 48,279,000USD | 43,793,000USD | 43,379,000USD | 59,413,000USD | 72,630,000USD | 86,702,000USD |
| Other Cashflows From Financing Activities | -333,000USD | — | 64,000USD | — | — | 83,000USD | 635,000USD | 377,000USD |
| Change To Account Receivables | — | — | — | 979,000USD | 1,117,000USD | 1,560,000USD | -1,323,000USD | -2,333,000USD |
| Issuance Of Capital Stock | — | — | — | — | — | 0USD | 0USD | 0USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | -3,817,000USD | -4,344,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|
| Net Income | -74,880,000USD | -9,725,000USD | -97,335,000USD | -109,872,000USD | -32,588,000USD | -22,964,000USD |
| Depreciation | 1,390,000USD | 1,593,000USD | 2,172,000USD | 2,414,000USD | 1,345,000USD | 715,000USD |
| Stock Based Compensation | 12,468,000USD | 14,554,000USD | 14,802,000USD | 13,350,000USD | 2,159,000USD | 1,371,000USD |
| Other Non Cash Items | -2,953,000USD | -4,392,000USD | -5,991,000USD | 152,000USD | 4,869,000USD | 2,593,000USD |
| Change To Account Receivables | 2,096,000USD | -1,559,000USD | -308,000USD | 2,500,000USD | -2,531,000USD | -2,531,000USD |
| Change In Working Capital | 3,910,000USD | -4,248,000USD | -4,613,000USD | -3,094,000USD | 6,522,000USD | 804,000USD |
| Total Cash From Operating Activities | -60,065,000USD | -2,218,000USD | -90,965,000USD | -97,050,000USD | -22,562,000USD | -20,074,000USD |
| Capital Expenditures | -314,000USD | -278,000USD | -508,000USD | -1,963,000USD | -8,981,000USD | -1,908,000USD |
| Free Cash Flow | -60,379,000USD | -2,496,000USD | -91,473,000USD | -99,013,000USD | -31,543,000USD | -21,982,000USD |
| Investments | 31,033,000USD | 32,230,000USD | -91,408,000USD | 14,376,000USD | -8,981,000USD | -1,908,000USD |
| Total Cashflows From Investing Activities | 30,719,000USD | 32,230,000USD | -36,692,000USD | 12,413,000USD | -8,981,000USD | -1,908,000USD |
| Total Cash From Financing Activities | 168,667,000USD | 2,746,000USD | 118,122,000USD | 84,323,000USD | 105,025,000USD | 17,662,000USD |
| Issuance Of Capital Stock | 164,500,000USD | 0USD | 117,296,000USD | 80,804,000USD | 105,095,000USD | — |
| Change In Cash | 139,321,000USD | 32,758,000USD | -9,535,000USD | -314,000USD | 73,482,000USD | -4,320,000USD |
| Begin Period Cash Flow | 59,413,000USD | 26,655,000USD | 36,190,000USD | 36,504,000USD | 407,000USD | 4,727,000USD |
| End Period Cash Flow | 198,734,000USD | 59,413,000USD | 26,655,000USD | 36,190,000USD | 73,889,000USD | 407,000USD |
| Unclassified Financing Cash Flow | 4,167,000USD | — | — | 81,047,000USD | -105,095,000USD | -35,213,000USD |
| Other Cashflows From Financing Activities | — | 2,746,000USD | 777,000USD | 3,519,000USD | 105,095,000USD | 35,283,000USD |
| Unclassified Investing Cash Flow | — | — | 55,224,000USD | -14,376,000USD | 8,981,000USD | 1,908,000USD |
| Change To Inventory | — | — | — | 1,246,000USD | 0USD | 0USD |
| Change To Liabilities | — | — | — | -4,398,000USD | -20,000USD | 208,000USD |
| Net Borrowings | — | — | — | -50,000USD | -70,000USD | -70,000USD |
| Sale Purchase Of Stock | — | — | — | -193,000USD | 105,095,000USD | 17,662,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -314,000USD | 0USD | 0USD |
| Other Cashflows From Investing Activities | — | — | — | 14,376,000USD | 0USD | 0USD |
| Dividends Paid | — | — | — | — | 0USD | 0USD |
| Exchange Rate Changes | — | — | — | — | 0USD | 0USD |
| Unclassified Operating Cash Flow | — | — | — | — | -4,869,000USD | -2,593,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.